Author/Authors :
Kevin J. Moriarty، نويسنده , , Michael Winters، نويسنده , , Lei Qiao، نويسنده , , Declan Ryan، نويسنده , , Renee DesJarlis، نويسنده , , Darius Robinson، نويسنده , , Brian N. Cook، نويسنده , , Mohammed A. Kashem، نويسنده , , Paul V. Kaplita، نويسنده , , Lisa H. Liu، نويسنده , , Thomas M. Farrell، نويسنده , , Hnin Hnin Khine، نويسنده , , Josephine King، نويسنده , , Steven S. Pullen، نويسنده , , Gregory P. Roth، نويسنده , , Ronald Magolda، نويسنده , , Hidenori Takahashi، نويسنده ,
Abstract :
Previously, we reported a series of novel benzimidazole based Itk inhibitors that exhibited excellent enzymatic potency and selectivity but low microsomal stability. Employing a structure based approach a new series of inhibitors with comparable potency and selectivity to the original series and with a potential for improved microsome stability was identified.
Keywords :
Itk inhibitor , SAR , Liver microsomes , Metabolic stability